PROPHYLAXIS OF BLEEDING
Clinical trials for PROPHYLAXIS OF BLEEDING explained in plain language.
Never miss a new study
Get alerted when new PROPHYLAXIS OF BLEEDING trials appear
Sign up with your email to follow new studies for PROPHYLAXIS OF BLEEDING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Personalized dosing for hemophilia a: one step closer?
Disease control CompletedThis study tested a new scoring method to help doctors choose the right dose of Jivi (a longer-lasting clotting factor) for people with hemophilia A. 21 participants switched from standard treatments to Jivi, and their dose plan was based on their personal risk score. The goal wa…
Matched conditions: PROPHYLAXIS OF BLEEDING
Phase: PHASE4 • Sponsor: Bayer • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for young hemophilia patients: fewer injections with BAY 94-9027
Disease control CompletedThis study looked at the safety of BAY 94-9027 (Jivi) in 36 children aged 7 to 12 with severe hemophilia A. The drug is a longer-lasting clotting factor that requires fewer injections. Researchers monitored for allergic reactions and whether the drug stopped working well during t…
Matched conditions: PROPHYLAXIS OF BLEEDING
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated May 22, 2026 13:50 UTC